Abstract
Infections due
to Klebsiella pneumoniae carbapenemase (KPC)-producing
56
Enterobacteriaceae are associated with therapeutic failure and increased mortality (1-5). It 57 has been suggested that antibiotic combination might be a better alternative when 58 compared to monotherapy for treatment of KPC-producing isolates (4-9); however, further 59 investigation on this therapeutic strategy is required (10, 11) .
60
In the present study, we evaluated efficacy of regimes for a KPC-KP strain in an experimental 61 model of systemic infection and in a time-kill assay (TKA).
63
A KPC-KP strain, coded RM-1209, was isolated from a patient's blood and identified by Vitek 
69
KPC-2 was confirmed at databases queried by NCBI BLAST (6).
70
The study was approved by the ethical committee, according to the Protocol for the 
119
PMB+TIG combination and triple therapy were synergistic whereas MER+TIG showed 120 antagonistic effect on TKA (Figure 3 ).
122
Evaluating survival and overall cultures sterilization, the better performance occurred with 
295
MER + TIG (D).
296
Bactericidal activity was defined as a ≥3 log 10 reduction in the total CFU/mL from the original 297 inoculum at 24 hours;
298
Bacteriostatic activity was defined as a <3 log 10 reduction in the total CFU/mL from the 299 original inoculum at 24 hours;
300
Synergism was defined as a difference of ≥ 2 log 10 in the reduction of the number of CFU/mL 301 between the combination and the most active agent at 24 hours;
302
Antagonism was defined as ≥ 2 log 10 increase of the number of CFU/mL between the 303 combination and the most active agent at 24 hours.
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